摘要
目的了解安徽省巢湖市城乡居民乙肝防治知识的掌握情况以及乙肝疫苗接种情况。方法采用分层整群抽样的方法,对巢湖市农村、城市居民1 565人进行问卷调查。结果1 565人中,曾经接种过乙肝疫苗者189人,乙肝疫苗接种率12.1%;其中全程接种139人,全程接种率为8.9%;曾经加强接种乙肝疫苗仅16人,占1.0%。乙肝疫苗接种率的有利影响因素为女性（OR=1.48,95%CI=1.09～2.01）、文化程度较高（OR=2.92,95%CI=2.40～3.54）、城市居民（OR=1.95,95%CI=1.44～2.66）、人均收入较高（OR=1.43;95%CI=1.23～1.66）;年龄较大（OR=0.42,95%CI=0.36～0.48）可能是乙肝疫苗接种率的不利影响因素。结论巢湖地区乙肝疫苗接种率在城市和农村分布特征不一致,影响乙肝疫苗接种率的因素为年龄、文化程度、城乡居住地等;加强乙肝相关知识宣传可能有助提高乙肝疫苗接种率水平,改善人们对乙肝疫苗接种的态度。
Objective In order to find out the status of cognition about hepatitis B and inoculation of hepatitis B vaccine among normal population in Chaohu city.Methods A cluster sampling method was conducted to perform questionnaire on 1 565 healthy persons which were selected randomly from urban and rural population of Chaohu.Results 1 565 persons were tested.There were statistic significances of the inoculation rate of hepatitis B vaccines between age groups,educational level,gender group,domestic economy status and urban/rural group.There were no statistic significance of the whole course vaccine inoculation rate between different gender group.However,the whole course vaccine inoculation rate in the different levels of age groups,educational level,domestic economy status and urban/rural group had statistic significances.The inoculation rate of hepatitis B vaccines was correlated with age groups,educational level,gender group,domestic economy status and urban/rural group.Conclusion The distribution characteristic of the inoculation of hepatitis B vaccines is different between cities and countryside.It was found that elder age,male,rural,educational level status were risk factors of inoculation rate of hepatitis B vaccines.Maybe the inoculation rate of hepatitis B vaccines could be raised,and pepole＇s attitude to type B hepatitis could be improved through enhancing propaganda of the cognition about hepatitis B.
出处
《中国公共卫生》
CAS
CSCD
北大核心
2008年第1期105-106,共2页
Chinese Journal of Public Health
基金
安徽省科技攻关项目(06013058A)
关键词
肝炎病毒
乙型
健康人群
乙型肝炎疫苗
hepatitis B virus
type B
normal population
viral hepatitis vaccine
